SON DAKİKA
--:--:--

Amwins Acquires Nelligan to Enhance Group Benefits Division

Discover how Amwins’ acquisition of Nelligan bolsters their Group Benefits Division, enhancing services and expanding market reach.

0 Yorum Yapıldı
Bağlantı kopyalandı!
Amwins Acquires Nelligan to Enhance Group Benefits Division
ffReklam 444

Amwins Acquires Nelligan to Enhance Group Benefits Division

In a strategic move to bolster its group benefits division, Amwins has acquired Nelligan, an independent general agency renowned for its specialization in group ancillary benefits. This acquisition aims to augment Amwins’ existing ancillary solutions, which include state disability, paid family and medical leave (PFML), and life and accidental death and dismemberment (AD&D).

Founded in 2008, Nelligan has earned a reputation for excellence in the ancillary benefits sector. With approximately $850 million in in-force premiums, over 400 broker relationships, and partnerships with more than 80 carriers across the U.S., Nelligan brings substantial experience and outreach to the Amwins family. The integration will see Nelligan’s 52 employees and market directors joining Amwins’ group benefits team.

“We’re committed to becoming the premier Ancillary General Agency partner in the market,” stated Riva Dumeny, President of Amwins Group Benefits. “Nelligan’s deep expertise and robust market presence make them the ideal partner to help us realize this vision. Together, we are expanding our product capabilities, strengthening our relationships, and enhancing our ability to provide even greater value to our partners.”

Nelligan CEO Bryan Herman conveyed his optimism about the partnership’s potential. “Both Nelligan employees and our customers will benefit from access to resources that support growth, enabling us to expand our services and deliver even greater value to the employee benefit industry,” he remarked.

Chris Wirth, President of Nelligan, added, “I am excited to collaborate on building the largest, industry-leading ancillary general agency in the market. The future of employee benefits excellence is truly here.”

This acquisition complements Amwins’ comprehensive offerings in self-funded, fully insured, and customized employee benefits programs. It also enhances Amwins’ $10 billion in in-force benefits premium and strengthens its collaboration with major carriers nationwide.

Dowling Hales served as the exclusive financial advisor to Nelligan, while Robinson, Bradshaw & Hinson provided legal counsel to Amwins.

Reklam 467Reklam 38

Yorum Yap

Benzer Haberler
Samsung One UI 8.5 expands to more devices: Here’s the list
Samsung One UI 8.5 expands to more devices: Here’s the list
Intel CEO Sends Clear Message: No Plans to Exit the GPU Business
Intel CEO Sends Clear Message: No Plans to Exit the GPU Business
AMD announces record-breaking results for Q4 and full year 2025
AMD announces record-breaking results for Q4 and full year 2025
Canlı Yayın | Manchester City-Newcastle United maçı ne zaman, saat kaçta, hangi kanalda?
Canlı Yayın | Manchester City-Newcastle United maçı ne zaman, saat kaçta, hangi kanalda?
Deportivo Alaves vs Real Sociedad match: Time, date and TV channel information
Deportivo Alaves vs Real Sociedad match: Time, date and TV channel information
Valencia vs Athletic Bilbao Live Stream: Match Time, Broadcast Channel and Probable Lineups
Valencia vs Athletic Bilbao Live Stream: Match Time, Broadcast Channel and Probable Lineups
En Güncel ve Doğru Haberler!
Sigorta Haber

Sigortahaber.com, sigorta sektöründeki en güncel haberleri, analizleri ve gelişmeleri tarafsız bir bakış açısıyla sunan bağımsız bir haber platformudur. Sigorta profesyonellerine, acentelere ve sektöre ilgi duyan herkese doğru, hızlı ve güvenilir bilgi sağlamayı amaçlıyoruz. Sigortacılıktaki yenilikleri, mevzuat değişikliklerini ve sektör trendlerini yakından takip ederek, okuyucularımıza kapsamlı bir bilgi kaynağı sunuyoruz.

2025 Sigorta Haber © Tüm hakları saklıdır. Sitemizde yer alan Ekonomi ve Finans kategorilerindeki içerikler yalnızca bilgilendirme amaçlıdır; herhangi bir yatırım tavsiyesi niteliği taşımaz. Sağlık ve Bilgi kategorisinde bulunan içerikler genel olarak yapay zekâ tarafından üretilmiş olup yalnızca bilgilendirme amacı taşır. Herhangi bir sağlık sorunu yaşıyorsanız, burada yer alan bilgileri esas almak yerine en kısa sürede uzman bir doktora başvurmanız önerilir.